📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
75
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split
55%
• 50-day avg $0.02 below $1 exchange minimum
💹 Market Data
Market Cap$1.83M
Shares Outstanding98.10M
Float11.34M
Cash$53.0K
Debt$9.34M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest33
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2013
xbrl
XBRL CONVERTIBLE
Dec 31, 2013
8-K
8K EVENT
Apr 20, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for AGSS
📊 AGSS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AGSS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.